- CNBC•13 hours ago
Credit Suisse analysts initiated shares of Allergan at an "outperform" rating, saying its diversified drug pipeline is underappreciated by investors.
After hours: 246.10-1.75 (-0.71%) as of 7:02 PM EDT
|Bid||236.50 x 200|
|Ask||252.78 x 300|
|52wk Range||195.50 - 340.34|
|Day's Range||246.09 - 250.29|
|Avg Vol (3m)||3,554,876|
As of 4:00 PM EDT. Market closed.